RetinaTek / Neurocognitive measurement

Making brain
performance
measurable.

Objective, repeatable cognitive measurement. Built on research. In development for concussion recovery.

Discuss a sponsored pilot Review the evidence
Illustration of a clinician fitting a headset for a supervised assessment.
RT-TRACE / In developmentIllustrative assessment setting

Controlled tasks. Eye movements. Pupil dynamics. Manual responses.

The RETINA platform

The measurement challenge

How is cognitive
performance changing?

Concussion recovery is variable. Measuring it consistently remains a challenge.

Symptoms and clinical judgment remain essential. RetinaTek is developing a complementary way to measure cognitive performance under controlled demand, repeatedly and practically.

RETINA synchronizes eye movements, pupil dynamics, and manual responses during structured cognitive tasks. The question is how the brain controls performance under cognitive load, as task demands vary from trial to trial.

How RETINA measures performance

Eye movements

How quickly and accurately the eyes respond to a task.

Pupil dynamics

Changes in pupil response under cognitive load.

Manual responses

Response speed, accuracy, and consistency during the same task.

Scientific foundation

The science behind
the measurement.

RETINA emerged from federally funded military and clinical research spanning attention, cognitive load, performance validity, TBI, and pupillometry.

Review the evidence and its limits
Published research

From visual attention to cognitive load

Read the peer-reviewed studies behind task-evoked measurement.

 Biological plausibility

The connection to brain biology

Research links task-evoked performance metrics with MRI findings at the group level.

 Measurement platform

From the laboratory to a headset

See how synchronized signals become cognitive-performance outputs.

Research today. Clinical development ahead.

A deliberate path to clinical use.

Concussion recovery is the commercial focus. Research use, the first clearance plan, and future condition-specific claims are distinct stages.

Current work

Research & sponsored pilots

Observational work alongside usual care, building evidence on workflow, utilization, and data quality.

Discuss a sponsored pilot

Planned first submission

RT-Focus

A computerized cognitive assessment aid. FDA feedback is informing the evidence and 510(k) submission plan.

Read the development plan

Future clinical development

RT-TRACE

Condition-specific development for adult and pediatric concussion specialty care, subject to validation and clearance.

See RT-TRACE

Investigational technology

RT-TRACE is not currently FDA-cleared, FDA-approved, or authorized to diagnose concussion or direct recovery decisions. Outputs do not currently determine diagnosis, treatment, benefits, or return-to-activity decisions. Disease-specific claims require appropriate validation and regulatory clearance.

Work with RetinaTek

Bring your
measurement question.

For clinics, research teams, and sponsors building evidence in cognitive performance and concussion recovery.

Talk with our team